| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Barrington Research analyst Michael Petusky maintains Henry Schein (NASDAQ:HSIC) with a Outperform and raises the price targ...
UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and lowers the price target from $82 to $80.
Henry Schein reports Q1 adjusted EPS at $1.10, down 9% Y/Y, with sales at $3.17 billion, up 3.7%. Guidance projects 2024 sales ...
2024 Adjusted EBITDA is expected to increase by more than 15% compared with 2023, unchanged from prior guidance
Henry Schein (NASDAQ:HSIC) reported quarterly earnings of $1.10 per share which beat the analyst consensus estimate of $1.01 by...
The analysis screened S&P 500 stocks that show an inverse correlation to Nvidia over a month and year period, following Nvi...
JP Morgan analyst Rachel Vatnsdal maintains Henry Schein (NASDAQ:HSIC) with a Overweight and raises the price target from $8...
